» Articles » PMID: 27229904

Strategies for Cell Membrane Functionalization

Overview
Specialty Biology
Date 2016 May 28
PMID 27229904
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The ability to rationally manipulate and augment the cytoplasmic membrane can be used to overcome many of the challenges faced by conventional cellular therapies and provide innovative opportunities when combined with new biotechnologies. The focus of this review is on emerging strategies used in cell functionalization, highlighting both pioneering approaches and recent developments. These will be discussed within the context of future directions in this rapidly evolving field.

Citing Articles

Utilizing bioprinting to engineer spatially organized tissues from the bottom-up.

Zhan Y, Jiang W, Liu Z, Wang Z, Guo K, Sun J Stem Cell Res Ther. 2024; 15(1):101.

PMID: 38589956 PMC: 11003108. DOI: 10.1186/s13287-024-03712-5.


Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics.

Jangid A, Kim S, Kim K Biomater Res. 2023; 27(1):59.

PMID: 37344853 PMC: 10283342. DOI: 10.1186/s40824-023-00404-8.


Cell augmentation strategies for cardiac stem cell therapies.

Cruz-Samperio R, Jordan M, Perriman A Stem Cells Transl Med. 2021; 10(6):855-866.

PMID: 33660953 PMC: 8133336. DOI: 10.1002/sctm.20-0489.


The Role of Paracrine Regulation of Mesenchymal Stem Cells in the Crosstalk With Macrophages in Musculoskeletal Diseases: A Systematic Review.

Xu H, Lee C, Wang Y, Huang S, Shin L, Wang Y Front Bioeng Biotechnol. 2020; 8:587052.

PMID: 33324622 PMC: 7726268. DOI: 10.3389/fbioe.2020.587052.


A blueprint for translational regenerative medicine.

Armstrong J, Keane T, Roques A, Patrick P, Mooney C, Kuan W Sci Transl Med. 2020; 12(572).

PMID: 33268507 PMC: 7610850. DOI: 10.1126/scitranslmed.aaz2253.


References
1.
McHugh R, Nagarajan S, Wang Y, Sell K, Selvaraj P . Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy. Cancer Res. 1999; 59(10):2433-7. View

2.
Brunschwig E, Fayen J, Medof M, Tykocinski M . Protein transfer of glycosyl-phosphatidylinositol (GPI)-modified murine B7-1 and B7-2 costimulators. J Immunother. 1999; 22(5):390-400. DOI: 10.1097/00002371-199909000-00002. View

3.
Chen A, Zheng G, Tykocinski M . Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method. J Immunol. 2000; 164(2):705-11. DOI: 10.4049/jimmunol.164.2.705. View

4.
Van Broekhoven C, Parish C, Vassiliou G, Altin J . Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development. J Immunol. 2000; 164(5):2433-43. DOI: 10.4049/jimmunol.164.5.2433. View

5.
SAXON E, Bertozzi C . Cell surface engineering by a modified Staudinger reaction. Science. 2000; 287(5460):2007-10. DOI: 10.1126/science.287.5460.2007. View